Epilepsy: new advances (Q39122505)

9 September 2017

Epilepsy: new advances (English)

1 reference

9 September 2017

3

1 reference

9 September 2017

4

Torbjörn Tomson

1 reference

9 September 2017

2

Emilio Perucca

1 reference

9 September 2017

Solomon L Moshé

1

1 reference

PubMed ID

25260236

9 September 2017

language of work or name

English

0 references

publication date

24 September 2014

1 reference

9 September 2017

1 reference

9 September 2017

385

1 reference

9 September 2017

884-898

1 reference

9 September 2017

9971

1 reference

Standards for epidemiologic studies and surveillance of epilepsy

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Psychosocial difficulties in people with epilepsy: a systematic review of literature from 2005 until 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Global disparities in the epilepsy treatment gap: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

1 reference

7 January 2021

Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

ILAE official report: a practical clinical definition of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Recommendation for a definition of acute symptomatic seizure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

How common are the "common" neurologic disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Estimation of the burden of active and life-time epilepsy: a meta-analytic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Epilepsy in poor regions of the world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Incidence of epilepsy: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Life expectancy in people with newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Temporal trends in the mortality of people with epilepsy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Premature mortality risk in people with convulsive epilepsy: long follow-up of a cohort in rural China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Unifying the definitions of sudden unexpected death in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Sudden unexpected death in epilepsy: current knowledge and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Epilepsy and risk of death and sudden unexpected death in the young: a nationwide study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Long-term mortality in childhood-onset epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Death in children with epilepsy: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Do psychiatric comorbidities have a negative impact on the course and treatment of seizure disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Epilepsy and psychiatric comorbidity: a nationally representative population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The somatic comorbidity of epilepsy: a weighty but often unrecognized burden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Epilepsy, suicidality, and psychiatric disorders: a bidirectional association.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Mutations affecting GABAergic signaling in seizures and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Neuronal circuits in epilepsy: do they matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The system epilepsies: a pathophysiological hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Evidence of an inhibitory restraint of seizure activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Early activation of ventral hippocampus and subiculum during spontaneous seizures in a rat model of temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Developmental patterns in the regulation of chloride homeostasis and GABA(A) receptor signaling by seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Epilepsy and epileptic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

1 reference

7 January 2021

Prolonged implantable electrocardiographic monitoring indicates a high rate of misdiagnosis of epilepsy--REVISE study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Recent advances in the molecular genetics of epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The pharmacological treatment of epilepsy in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Quantifying the response to antiepileptic drugs: effect of past treatment history

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Patterns of treatment response in newly diagnosed epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Comparative safety of antiepileptic drugs during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Remission and relapse in a drug-resistant epilepsy population followed prospectively

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Combination therapy in epilepsy: when and what to use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Antiepileptic drug therapy: does mechanism of action matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The pharmacology of new antiepileptic drugs: does a novel mechanism of action really matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Determinants of quality of life after epilepsy surgery: systematic review and evidence summary.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The reliability and validity of the Revised Liverpool Impact of Epilepsy Scale for use in people with new-onset epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Drug-resistant epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Novel medications for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

New and forthcoming anti-epileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Perampanel: as adjunctive therapy in patients with partial-onset seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

What is the evidence to use new intravenous AEDs in status epilepticus?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Intramuscular versus intravenous therapy for prehospital status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Efficacy of buccal midazolam compared to intravenous diazepam in controlling convulsions in children: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

A randomized, controlled trial of surgery for temporal-lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Practice parameter: temporal lobe and localized neocortical resections for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Epilepsy surgery trends in the United States, 1990-2008.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Referral pattern for epilepsy surgery after evidence-based recommendations: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Improved outcomes with earlier surgery for intractable frontal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Barriers toward epilepsy surgery. A survey among practicing neurologists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Development of an online tool to determine appropriateness for an epilepsy surgery evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Morphometric MRI analysis improves detection of focal cortical dysplasia type II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The value of magnetoencephalography for seizure-onset zone localization in magnetic resonance imaging-negative partial epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Functional imaging: II. Prediction of epilepsy surgery outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Electroencephalographic source imaging: a prospective study of 152 operated epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

With or without spikes: localization of focal epileptic activity by simultaneous electroencephalography and functional magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Imaging memory in temporal lobe epilepsy: predicting the effects of temporal lobe resection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Optic radiation tractography and vision in anterior temporal lobe resection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Stereoelectroencephalography: surgical methodology, safety, and stereotactic application accuracy in 500 procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Stereoelectroencephalography in the "difficult to localize" refractory focal epilepsy: early experience from a North American epilepsy center.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Risks and benefits of invasive epilepsy surgery workup with implanted subdural and depth electrodes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

SEEG-guided thermocoagulations: a palliative treatment of nonoperable partial epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Stereo-EEG-guided radio-frequency thermocoagulations of epileptogenic grey-matter nodular heterotopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Single pulse electrical stimulation for identification of structural abnormalities and prediction of seizure outcome after epilepsy surgery: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Time-frequency analysis of single pulse electrical stimulation to assist delineation of epileptogenic cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

High-frequency electroencephalographic oscillations correlate with outcome of epilepsy surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

The hidden causes of surgery-resistant temporal lobe epilepsy: extratemporal or temporal plus?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Seizure outcomes following multilobar epilepsy surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Ictal clinical and scalp-EEG findings differentiating temporal lobe epilepsies from temporal 'plus' epilepsies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Multi-focal occurrence of cortical dysplasia in epilepsy patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Predictors of seizure outcomes in children with tuberous sclerosis complex and intractable epilepsy undergoing resective epilepsy surgery: an individual participant data meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

A multicenter, prospective pilot study of gamma knife radiosurgery for mesial temporal lobe epilepsy: seizure response, adverse events, and verbal memory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Withdrawal of antiepileptic drugs after neocortical epilepsy surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Timing of antiepileptic drug withdrawal and long-term seizure outcome after paediatric epilepsy surgery (TimeToStop): a retrospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Responsive cortical stimulation for the treatment of medically intractable partial epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

In search of epilepsy biomarkers in the immature brain: goals, challenges and strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Acute EEG findings in children with febrile status epilepticus: results of the FEBSTAT study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Networks involved in seizure initiation. A reading epilepsy case studied with EEG-fMRI and MEG.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Identification of new epilepsy treatments: issues in preclinical methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Therapeutic approaches to epileptogenesis--hope on the horizon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

ILAE/IBE/WHO Global Campaign Against Epilepsy: a partnership that works

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960456-6

7 January 2021

10.1016/S0140-6736(14)60456-6

Identifiers

DOI

1 reference

9 September 2017

1 reference

PubMed ID

25260236